HOME >> MEDICINE >> NEWS
Protecting children from industrial chemicals in the environment

American children are likely to face serious health consequences from new and existing industrial chemicals in the environment, argue a group of researchers in a report in this month's premier open-access global health journal PLoS Medicine.

Women exposed to industrial chemicals in the environment pass them on to their children across the placenta or via breast milk, and children are also exposed to chemicals by direct ingestion of house dust, soil, and other dietary sources during early childhood. The vast majority of these chemicals, say the researchers, have never been tested to ensure that they are safe for the developing fetus or child.

While the exact consequences of exposing children to these chemicals are unknown, the researchers - Bruce Lanphear and Charles Vorhees at the Cincinnati Children's Hospital Medical Center, University of Cincinnati, and David Bellinger at Harvard Medical School - say that "exposures to environmental toxins have been linked with higher rates of mental retardation, intellectual impairment, and behavioral problems, such as conduct disorder and attention deficit hyperactivity disorder."

A crucial step towards protecting children would be to ensure that industrial chemicals undergo "developmental neurotoxicity testing." Such testing uses animal experiments to provide information on what happens to the fetal nervous system, and the newborn child's nervous system, when it is exposed to an industrial chemical during pregnancy or while breast feeding. Unfortunately, argue Lanphear and colleagues, the most basic toxicity tests in animals are lacking for 75% of the 3,000 highest production volume chemicals.

Under current regulations, they say, manufacturers of commercial chemicals have no legal obligation to prove that their chemicals are non-toxic before marketing them. While the US Environmental Protection Agency (EPA) has entered into an agreement with the American Chemistry Council
'"/>

Contact: Paul Ocampo
pocampo@plos.org
1-415-624-1224
Public Library of Science
28-Mar-2005


Page: 1 2

Related medicine news :

1. Protecting human subjects focus of national FDA conference at UH
2. Protecting against heart attack: The beat goes on thanks to erythropoietin
3. Bridge Medical HIMSS media briefing: Protecting Children with a Technology Safety Net
4. Protecting babies from RSV could reduce the chances of wheeze and asthma during childhood
5. BioNumerik Reports The Supercomputer Supported Discovery Of New, Non-Toxic Chemotherapy Protecting Agent
6. Protecting Breast Feeding From Breast Milk Substitutes
7. Study finds majority of women willing to accept cervical cancer vaccine for self and children
8. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
9. Use of inhaled corticosteroid led to fewer hospitalizations for young children with asthma
10. Pushy parents can be bad for their childrens health
11. Cavity prevention tips for pre-school age children

Post Your Comments:
(Date:5/21/2013)... An attack on glioblastoma brain tumor cells that ... an early study to establish the proper dose level, ... developed at Duke and tested in an ongoing phase ... have an abundance of receptors that work like magnets ... cells. , The investigational therapy, known as PVSRIPO, ...
(Date:5/21/2013)... Adeptia, a leading provider of innovative cloud ... is the featured company in an impact report written ... “Adeptia Bets on Converged Cloud Integration and Process-Orchestration Suites,” ... products, pricing, customers and competition. , “For ... integration and process orchestration, especially when price, ease of ...
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... some of the changes brought about by the disorder ... New research has found that people with diabetes who ... risk of having a severe low blood sugar (hypoglycemia) ... people with diabetes who aren,t depressed. "Depression ...
(Date:5/21/2013)... Grapefruits have long been known for their ... how medical therapies like anti-cancer drugs are delivered ... researchers have uncovered how to create nanoparticles using ... how to use them as drug delivery vehicles. ... Ph.D., and their team today (May 21, 2013), ...
(Date:5/21/2013)... May 21, 2013 Benefit Express Services, ... medium, and small organizations, will be hosting a free ... team from Findley Davies. The presentation will focus on ... in compliance with new Health Care Reform Requirements. The ... employees. , “Benefit Express regularly hosts free educational ...
Breaking Medicine News(10 mins):Health News:Poliovirus vaccine trial shows early promise for recurrent glioblastoma 2Health News:Adeptia Featured in Recent 451 Research Impact Report 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3Health News:UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery 2Health News:Benefit Express to Host Workplace Wellness Webinar 2
(Date:5/21/2013)...  Janssen R&D Ireland (Janssen) today announced primary ... 3 PROMISE study demonstrating that use of the ... virologic response 12 weeks after the end of ... 1 chronic hepatitis C adult patients with compensated ... when administered once daily with pegylated interferon and ...
(Date:5/21/2013)... 2013 Abaxis, Inc. (NasdaqGS: ABAX), a medical ... that Martin Mulroy , chief commercial ... & Veterinary Conference on Wednesday, May 29, 2013 at ... Le Parker Meridien Hotel in New York ... Abaxis develops, manufactures, markets and sells portable blood analysis ...
(Date:5/21/2013)... 2013  BioRestorative Therapies, Inc. ("BRT" or the "Company") ... developing stem cell based therapies for various personal applications, ... President and CEO, will be presenting at the Marcum ... held on Thursday, May 30, 2013 at the Grand ... New York City.  Mr. Weinreb,s presentation will take place ...
Breaking Medicine Technology:Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3
Cached News: